Real-World Treatment Patterns and Outcomes of Zanubrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at University of California Academic Health Centers: A Retrospective Cohort Study
Open Access
- 30 October 2026
- journal article
- research article
- Published by Springer Nature in Oncology and Therapy
- p. 1-21
Abstract
No abstract availableKeywords
Funding Information
- BeOne Medicines, Ltd
This publication has 59 references indexed in Scilit:
- 210 | REAL‐WORLD COMPARATIVE EFFECTIVENESS OF FIRST‐LINE BRUTON TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIAHematological Oncology, 2025
- Detecting New Lesions Using a Large Language Model: Applications in Real‐World Multiple Sclerosis DatasetsAnnals of Neurology, 2025
- Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and TherapyAmerican Journal of Hematology, 2025
- Relative efficacy of systemic treatments for patients with relapsed/refractory chronic lymphocytic leukemia: a network meta-analysis according to 17p deletion/TP53 mutationsBlood Research, 2025
- Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United StatesBlood Neoplasia, 2024
- Efficacy and safety of new-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia/small lymphocytic lymphoma: a systematic review and meta-analysisAnnals of Hematology, 2023
- A matching‐adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemiaAmerican Journal of Hematology, 2023
- Diagnosis and Treatment of Chronic Lymphocytic LeukemiaJAMA, 2023
- Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database StudyClinical Lymphoma Myeloma and Leukemia, 2022
- Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemiaCancer, 2013